| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.02. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2025 | 165 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its Year-end report for January - December 2025.Highlights of the Year-end report 2025The year 2025 represents... ► Artikel lesen | |
| 08.01. | Clinical Laserthermia Systems AB: TRANBERG Thermal Therapy System installed at Andros Clinics for Launch of Ultrasound-Guided Focal Laser Ablation Program in The Netherlands | 1 | Cision News | ||
| 12.12.25 | Clinical Laserthermia Systems AB: CLS initiates recruitment process for permanent Chief Financial Officer | 161 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS") today announces that the company has decided to transition from its current interim, part-time consulting CFO arrangement to a permanent and fully employed... ► Artikel lesen | |
| 03.12.25 | Clinical Laserthermia Systems Submits CE-Marking Application for its ClearPoint Prismbranded Neuro Laser Therapy System seeking European Regulatory Approval for use in Neurosurgery | 1 | Cision News | ||
| 14.11.25 | Clinical Laserthermia Systems AB: CLS Publishes Interim Report January - September 2025 | 888 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - September 2025.Highlights of the Third Quarter Interim ReportDuring the... ► Artikel lesen | |
| 07.10.25 | Clinical Laserthermia Systems AB: CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results | 146 | GlobeNewswire (Europe) | Lund, Sweden, October 7th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS") today announces positive results from a clinical safety study on laser ablation, performed using CLS proprietary LITT... ► Artikel lesen | |
| 30.09.25 | Clinical Laserthermia Systems AB Raises SEK 20.9 Million Through Full Subscription of Warrants of Series TO 8 B | 2 | Cision News | ||
| CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 04.09.25 | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT | 287 | GlobeNewswire (Europe) | Lund, Sweden - September 4th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for expansion... ► Artikel lesen | |
| 22.08.25 | Clinical Laserthermia Systems AB: CLS publishes half-year report January - June 2025 | 281 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half year report January - June 2025. Second Quarter Highlights
Record sales revenue of SEK 9,4M... ► Artikel lesen | |
| 16.05.25 | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Interim report for January - March 2025 | 256 | GlobeNewswire (Europe) | Summary of the interim report (relates to the Group)Three months (01/01/2025-03/31/2025)
Net sales totaled SEK 4,496,000 (SEK 3,140,000).
Operating profit totaled SEK -7,868,000 (SEK -16,992,000).
Profit/loss... ► Artikel lesen | |
| 28.04.25 | ClearPoint Neuro, Inc.: ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism to Include 1.5 T MRI | 246 | ACCESS Newswire | SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the... ► Artikel lesen | |
| 15.04.25 | Clinical Laserthermia Systems AB: Updated clinical guidelines provide clear recommendations on the use of Laser Interstitial Thermal Therapy (LITT) in patients with metastatic brain tumors and radiation necrosis | 288 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS or the "Company") today announces that updated clinical guidelines with recommendations supporting the use of Laser Interstitial Thermal Therapy (LITT)... ► Artikel lesen | |
| 08.04.25 | Clinical Laserthermia Systems AB: Proposed U.S. tariffs expected to have minimal impact on CLS business | 211 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") clarifies that the proposed U.S. tariffs are expected to have minimal impact on its total business, including operations... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,680 | +0,60 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius von 55 auf 57 Euro angehoben und die Einstufung auf "Buy" belassen. Analyst James Vane-Tempest hob am Sonntag im... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 24,600 | -3,07 % | INDEX-MONITOR: Lufthansa verpasst Dax-Rückkehr - Nur Wechsel in MDax und SDax | ZUG (dpa-AFX) - Die Aktien von Lufthansa haben die Rückkehr in den deutschen Leitindex Dax verpasst. Wie der zur Deutschen Börse gehörende Index-Anbieter Stoxx am späten Mittwochabend mitteilte, bleibt... ► Artikel lesen | |
| DRAEGERWERK | 85,10 | -3,08 % | DRAEGERWERK AG & CO KGAA ST zeigt strukturelle Schwäche | ||
| MEDTRONIC | 77,41 | -1,11 % | Medtronic's MiniMed Group Prices IPO Of 28 Mln Shares At $20.00/shr | WASHINGTON (dpa-AFX) - MiniMed Group Inc., a subsidiary of Medtronic plc (MDT), announced the pricing of its initial public offering of 28 million shares of its common stock at a price to the... ► Artikel lesen | |
| INTUITIVE SURGICAL | 418,55 | -0,92 % | Intuitive Surgical: Steht ein weiterer Rücksetzer bevor? | Die Intuitive-Surgical-Aktie zeigt seit dem Jahreswechsel eine deutlich schwächere Struktur. Rutscht der Kurs in Richtung der nächsten Unterstützung ab Den vollständigen Artikel lesen ... ► Artikel lesen | |
| THERMO FISHER | 428,15 | -0,99 % | Thermo Fisher Opens Bay Area Cryo-EM Drug Discovery Center | ||
| TELADOC HEALTH | 4,320 | -1,22 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 | ||
| ROKU | 83,77 | -3,32 % | Aurzen Roku TV Smart Projector Review: I Wish More Projectors Had Roku Built-In | ||
| HIMS & HERS HEALTH | 19,085 | +40,64 % | Kreise: Novo Nordisk und Hims &Hers beenden Streit mit GLP-1-Partnerschaft | LONDON (dpa-AFX) - Der Streit um den Verkauf von Abnehmmedikamenten zwischen dem dänischen Pharmakonzern Novo Nordisk und dem US-Telemedizinanbieter Hims & Hers dürfte durch eine Kooperation der beiden... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,109 | +3,81 % | Sernova Biotherapeutics: Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - March 4, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSHO) ("Sernova" or the "Company"), a leading regenerative medicine... ► Artikel lesen | |
| ALCON | 69,22 | -2,56 % | Alcon Surpasses 175 Million IOLs Implanted Globally | Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction... ► Artikel lesen | |
| DEXCOM | 58,49 | -0,29 % | Demystifying DexCom: Insights From 12 Analyst Reviews | ||
| RESMED | 211,10 | -3,12 % | Resmed, Inc.: Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach | Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains
53% of people surveyed rank sleep as the most important behavior for a long... ► Artikel lesen | |
| HEALWELL AI | 0,559 | -5,81 % | HEALWELL AI gibt Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2025 am 19. März 2026 bekannt | - HEALWELL AI wird am Freitag, den 20. März 2026, um 8:30 Uhr ET (5:30 Uhr PT) eine Telefonkonferenz und einen gleichzeitigen Webcast abhalten
TORONTO, ON, 9. März 2026 /... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,590 | -2,25 % | Ki Reply und Data Reply legen mit "Cerebra" das strategische Fundament für KI-Innovationen bei Siemens Healthineers | Ki Reply und Data Reply, Experten für KI-gestützte Softwareentwicklung und datengetriebene Lösungen innerhalb der Reply Gruppe, haben gemeinsam mit der Abteilung "CRM Excellence" von Siemens Healthineers... ► Artikel lesen |